Zidesamtinib (NVL-520) is an orally active, selective, potent, and blood-brain-barrier-crossing inhibitor of ROS1 fusion and resistance mutations, inhibits ROS1 and ROS1 G2032R, and can be used in the study of non-small-cell lung cancer and solid tumors.
Molecular Weight:
419.455
Purity:
99.78%
CAS Number:
[2739829-00-4]
Formula:
C22H22FN7O
Target:
ROS Kinase
T72953
* VAT and and shipping costs not included. Errors and price changes excepted